Start with the formulation being studied
HCL is shorthand for creatine hydrochloride. Monohydrate is the form used across much of the established supplementation literature. Their names describe chemical forms, instead of a ranking of product quality. A claim that one dissolves more readily needs to be distinguished from evidence that it produces better results in people. The review in our library discusses alternative forms and the difference between chemical properties and demonstrated benefits. When reading a comparison, check whether it actually measured a relevant outcome or simply described solubility, a proposed mechanism or a marketing rationale. Those are different kinds of evidence. Read the source
Why grams need an identified basis
A gram figure is meaningful only when the label identifies what is being counted. Creatine monohydrate mass and a stated creatine equivalent are different reporting bases. A hydrochloride amount should not silently be placed on the same scale as a monohydrate amount and described as equivalent. Our separate comparison site uses declared monohydrate mass for its common unit. That is an arithmetic convention, instead of proof that a larger number is medically preferable. Before comparing prices, check the exact formulation, the labelled serving and the amount basis. A capsule count alone cannot establish the amount supplied by the entire pack. Read the source
The small trial in peri- and postmenopausal women
The CONCRET-MENOPA trial in the evidence library studied 36 peri- and postmenopausal women over eight weeks. Its groups used HCL at 750 or 1,500 mg per day, an HCL and ethyl-ester combination at 800 mg per day, or placebo. Selected reaction-time and brain-creatine measures differed, but the primary mental-fatigue outcome did not show a significant treatment-by-time effect. These details belong beside any headline about the trial. It was a small study split across several groups, with multiple outcomes. It should not be presented as establishing a treatment for brain fog or a reliable improvement for every woman. Read the source
What that trial did not compare
The trial's listed groups did not include a creatine monohydrate arm. It therefore cannot establish that HCL outperforms monohydrate, or that a smaller HCL amount is equivalent to a particular monohydrate protocol. Its population also cannot be expanded into a claim about all adults or every stage of menopause. The record in our library retains the primary negative finding alongside selected differences in other measures. It notes industry funding and disclosed relationships as part of interpreting the work. A result within one group is also different from a treatment effect demonstrated against the comparison group. Read the source
Evidence about another form stays with that form
Research on a different alternative formulation cannot simply be renamed as an HCL study. The buffered-creatine trial in our library concerns buffered creatine and monohydrate. It is useful for illustrating why a product's claimed advantage needs to be tested, but it does not provide a direct HCL comparison. This is the same reason evidence from one finished gummy cannot verify another brand. Keep the compound, formulation and measured outcome visible. Our forms guide separates the research records so a shopper can follow the actual intervention. The existence of many creatine studies does not mean every new formulation inherits all of their findings. Read the source
Use research and labels for their own questions
Research can help assess an outcome claim when the population, protocol and comparison are relevant. A current product label helps identify what a specific pack declares. Neither replaces the other. For shopping, check the form, serving definition, added ingredients, source date and testing identity before comparing cost. For symptoms or personal suitability, speak with your GP, especially during pregnancy or breastfeeding, with kidney disease, when taking medication or for someone under eighteen. A formulation name does not provide a safety rating. Follow the links below to read the underlying evidence and keep the product question separate from an individual health decision. Read the source
Continue reading
Sources checked
- Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show?
review. Mixed populations across the reviewed research. A narrative review, not one trial. Populations and methods differ. Several authors report supplement-industry relationships.
- International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine
position stand. Mixed populations in the reviewed research. A position statement synthesising varied research. It is not an individual dosing prescription. Several authors disclose industry relationships.
- The Effects of 8-Week Creatine Hydrochloride and Creatine Ethyl Ester Supplementation on Cognition, Clinical Outcomes, and Brain Creatine Levels in Perimenopausal and Menopausal Women (CONCRET-MENOPA): A Randomized Controlled Trial
RCT. 36 peri- and postmenopausal women, mean age about 50. 36 participants across four groups; multiple outcomes and alternative forms. Partly funded by Vireo Systems; author creatine-industry relationships disclosed. Does not establish a treatment for brain fog.
- A buffered form of creatine does not promote greater changes in muscle creatine content, body composition, or training adaptations than creatine monohydrate
RCT. 36 resistance-trained young men completed the trial. Small, short male-only trial. Results for this buffered formulation do not settle every alternative form. Industry funding disclosed.
Checked against these published source records on 4 November 2026. General information only, not medical advice.